Media ReleasesArovella Therapeutics

View All Arovella Therapeutics News


SUDA Pharmaceuticals Announces Prospectus For Entitlement Offer


Non-renounceable pro rata entitlement offer of 1 New Share for every 1 Existing Share (and 1 New Option for every 3 New Shares issued) at an offer price of $0.025 per New Share to raise approximately $3.56 million (before the exercise of any New Options).

Last date for acceptance and payment: 5.00pm (Sydney time) on Wednesday, 22 July 2020.

For more information, download the attached PDF.

Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?